Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006

BMC Psychiatry

Peter Krantz¹  Morten Hesse²  Martin Bäckström⁴  Mats Fridell³  Anna Nyhlén⁵ 

[1] Dept of Forensic Medicine Lund University Hospital, S - 221 85 Lund, Sweden;University of Aarhus, Centre for Alcohol and Drug Research Artillerivej 90, 2300 Copenhagen S, Denmark;Lund University, Dept of Psychology & Vaxjo University, School of Education, Psychology and Sport Science, SE - 35195, Växjö, Sweden;Lund University, Dept of Psychology B 213, SE - 221 00 Lund, Sweden;Dept of Psychiatry Lund University Hospital SE - 221 85 Lund, Sweden

关键词: Predictors;    cohort study;    competing risks Cox regression;    gender;    risk factor;    drug related death;   

Others  :  1124514
DOI  :  10.1186/1471-244X-11-122

 received in 2010-09-27, accepted in 2011-07-30,  发布年份 2011

【 摘 要 】

Background

Few longitudinal cohort studies have focused on the impact of substances abused and psychiatric disorders on premature mortality. The aim of the present study was to identify predictors of increased risk of drug related death and non drug related death in substance abusers of opiates, stimulants, cannabis, sedatives/hypnotics, hallucinogens and alcohol over several decades.

Methods

Follow-up study of a consecutive cohort of 561 substance abusers, admitted to a detoxification unit January 1970 to February 1978 in southern Sweden, and followed up in 2006. Demographic and clinical data, substance diagnoses and three groups of psychiatric diagnoses were identified at first admission. Causes of death were coded according to ICD-10 and classified as drug related deaths or non drug related deaths. To identify the incidence of some probable risk factors of drug related premature death, the data were subjected to a competing risks Cox regression analysis.

Results

Of 561 patients in the cohort, 11 individuals had either emigrated or could not be located, and 204/561 patients (36.4%) were deceased by 2006. The cumulative risk of drug related death increased more in the first 15 years and leveled out later on when non drug related causes of death had a similar incidence. In the final model, male gender, regular use of opiates or barbiturates at first admission, and neurosis were associated with an increased risk of drug related premature death, while cannabis use and psychosis were associated with a decreased risk. Neurosis, mainly depression and/or anxiety disorders, predicted drug related premature death while chronic psychosis and personality disorders did not. Chronic alcohol addiction was associated with increased risk of non drug related death.

Conclusions

The cohort of drug abusers had an increased risk of premature death to the age of 69. Drug related premature death was predicted by male gender, the use of opiates or barbiturates and depression and anxiety disorders at first admission. The predicted cumulative incidence of drug related death was significantly higher in opiate and barbiturate abusers over the observed period of 37 years, while stimulant abuse did not have any impact. Alcohol contributed to non drug related death.

【 授权许可】

   
2011 Nyhlén et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Bejerot N: Drug abuse and drug policy. An epidemiological and methodological study of drug abuse of intravenous type in the Stockholm police arrest population 1965--1970 in relation to changes in drug policy. Acta Psychiatrica Scandinavica 1975, 256(Suppl):3-277.
• [2]Frykholm B: Changes in short-term prognosis-a comparison between Swedish amphetamine and opiate abusers. Drug and Alcohol Dependence 1980, 5(2):123-8.
• [3]Bartu A, Freeman NC, Gawthorne GS, et al.: Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia. Addiction 2004, 99(1):53-60.
• [4]Wahren CA, Brandt L, Allebeck P: Has mortality in drug addicts increased? A comparison of two hospitalized cohorts in Stockholm. International Journal of Epidemiology 1997, 26(6):1219-1226.
• [5]Barr HL, Antes D, Ottenberg DJ, Rosen A: Mortality of treated alcoholics and drug addicts: the benefits of abstinence. Journal of Studies on Alcohol 1984, 45(5):440-52.
• [6]Tunving K: Fatal outcome in drug addiction. Acta Psychiatrica Scandinavica 1988, 77(5):551-66.
• [7]Skurtveit S, Christophersen AS, Grung M, Morland J: Increased mortality among previously apprehended drunken and drugged drivers. Drug and Alcohol Dependence 2002, 68(2):143-150.
• [8]Chen CC, Kuo CJ, Tsai SY: Causes of death of patients with substance dependence: a record-linkage study in a psychiatric hospital in Taiwan. Addiction 2001, 96(5):729-36.
• [9]Sørensen HJ, Jepsen PW, Haastrup S, Juel K: Drug-use pattern, comorbid psychosis and mortality in people with a history of opioid addiction. Acta Psychiatrica Scandinavica 2005, 111:244-249.
• [10]Copeland L, Budd J, Robertson JR, Elton RA: Changing patterns in causes of death in a cohort of injecting drug users, 1980-2001. Archives of Internal Medicine 2004, 164(11):1214-20.
• [11]Risser D, Honigschnabl S, Stichenwirth M, et al.: Mortality of opiate users in Vienna, Austria. Drug Alcohol Dependence 2001, 64(3):251-6.
• [12]Rehm J, Frick U, Hartwig C, et al.: Mortality in heroin-assisted treatment in Switzerland 1994-2000. Drug and Alcohol Dependence 2005, 79(2):137-43.
• [13]Degenhardt LJ, Roxburgh A, Barker B: Underlying causes of cocaine, amphetamine and opioid related deaths in Australia. Journal of Clinical Forensic Medicine 2005, 12(4):187-195.
• [14]Brugal MT, Domingo-Salvany A, Puig R, et al.: Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005, 100(7):981-9.
• [15]Gossop M, Stewart D, Treacy S, Marsden J: A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002, 97(1):39-47.
• [16]Oppenheimer E, Tobutt C, Taylor C, Andrew T: Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction 1994, 89(10):1299-308.
• [17]Ghodse AH, Oyefeso A, Kilpatrick B: Mortality of drug addicts in the United Kingdom 1967-1993. International Journal of Epidemiology 1998, 27:473-478.
• [18]Frischer M, Bloor M, Goldberg D, et al.: Mortality among injecting drug users: a critical reappraisal. Journal of Epidemiology and Community Health 1993, 47:59-63.
• [19]Fridell M, Hesse M, Jaeger MM, Kühlhorn E: Antisocial personality disorder as a predictor of criminal behaviour in a longitudinal study of a cohort of abusers of several classes of drugs: relation to type of substance and type of crime. Addictive Behaviours 2008, 33(6):799-811.
• [20]Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H: Overview of amphetamine- type stimulant mortality data -UK, 1997-2007. Neuropsychobiology 2010, 61(3):122-130.
• [21]Oyefeso A, Schifano F, Ghodse H, et al.: Fatal injuries while under the influence of psychoactive drugs: a cross-sectional exploratory study in England. BMC Public Health 2006, 6;6:148.
• [22]Fridell M, Hesse M: Psychiatric severity and mortality in substance abusers: a 15-year follow-up of drug users. Addictive Behaviours 2006, 31(4):559-65.
• [23]Tungt narkotikamissbruk. En särredovisning för län och kommuner av 1979-års undersökning In UNO, Heavy drug use: A special report for counties and municipalities of the 1979 study. Stockholm, Liber förlag; 1980.
• [24]Berglund GW, Bergmark A, Björling B, et al.: The SWEDATE Project: interaction between treatment, client background, and outcome in a one-year follow-up. Journal of Substance Abuse Treatment 1991, 8(3):161-9.
• [25]The ICD-10 classification of mental and behavioural disorders and somatic diseases. Geneva, WHO; 1993.
• [26]Bargagli AM, Hickman M, Davoli M, et al.: Drug-related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health 2006, 16(2):198-202.
• [27]Pintilie M: Analysing and interpreting competing risk data. Statistics in Medicine 2007, 26(6):1360-7.
• [28][http://www.scb.se] webciteSwedish Central Bureau of Statistics, SCB. Sweden, SCB; 1980. SCB 2006
• [29]EMCDDA: Drug related deaths and mortality. In Annual report on the state of the drugs problem in Europe/EMCDDA. Lisbon; 2010:87-92.
• [30]Ravndal E, Vaglum P: Overdoses and suicide attempts: different relations to psychopathology and substance abuse? A five-year prospective study of drug abusers. European Addiction Research 1999, 5(2):63-70.
• [31]Hulse GK, English DR, Milne E, Holman CDJ: The quantification of mortality resulting from the regular use of illicit opiates. Addiction 1999, 94(2):221-9.
• [32]Darke S, Zador D: Fatal heroin overdose: a review. Addiction 1996, 91(12):1765-1772.
• [33]White JM, Irvine RJ: Mechanisms of fatal opioid overdose. Addiction 1999, 94:961-972.
• [34]Andreasson S, Allebeck P: Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scandinavian Journal of Social Medicine 1990, 18(1):9-15.
• [35]Sidney S, Beck JE, Tekawa IS, et al.: Marijuana use and mortality. American Journal of Public Health 1997, 87(4):585-90.
• [36]Hser Y-I, Hoffman V, Grella CE, Anglin MD: A 33 year follow-up of narcotics addicts. Archives of General Psychiatry 2001, (58):503-508.
• [37]Baldacchino A, Corkery J: Comorbidity research in Europe. In European Collaborating Centres in Addiction Studies (ECCAS) ECCAS Monograph Series no 4. London; 2006:307-330.
• [38]Nilsson M, Fridell M, Griffiths P: Comorbidity-developing an European perspective. In European Collaborating Centres in Addiction Studies (ECCAS) ECCAS Monograph Series no 4. London; 2006:351-363.
• [39]Bogren M, Mattisson C, Isberg P-E, Nettelbladt P: How common are psychotic and bipolar disorders? A 50-year follw-up of the Lundby population. Nordic Journal of Psychiatry 2009, (63):336-346.
• [40]Nettelbladt P, Bogren M, Mattisson C, et al.: Does it make sense to do repeated surveys?-the Lundby Study, 1947-1997. Acta Psychiatrica Scandinavica 2005, (111):444-452.
• [41]Nyhlén A, Fridell M, Hesse M, Krantz P: Causes of premature mortality in Swedish drug abusers: A prospective longitudinal study 1970-2006. Journal of Forensic and Legal Medicine 2011, 18:66-72.
• [42]Di Castelnuovo A, Costanzo S, Bagnardi V, et al.: Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Archives of Internal Medicine 2006, 166(22):2437-45.
• [43]Szasz T: The Discovery of drug addiction. In Ceremonial Chemistry. Anchor Press; New York; 1974:3-18.